Presence of genotypic resistance to antiretroviral drugs in a cohort of therapy-naive HIV-1-infected Italian patients [1]

Journal of Acquired Immune Deficiency Syndromes

Volumn 27, Issue 3, 2001, Pages 315-316

  Re, Maria Carla ^a   Monari, Paola ^a   Borderi, Marco ^a   Tadolini, Marina ^a   Verucchi, Gabriella ^a   Vitone, Francesca ^a   Spinosa, Sabrina ^a   La Placa, Michele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COMPLEMENTARY DNA; DELAVIRDINE; EFAVIRENZ; NEVIRAPINE; PROTEINASE; RNA DIRECTED DNA POLYMERASE; VIRUS RNA;

CLINICAL ARTICLE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; LETTER; PRIORITY JOURNAL; VIRUS MUTATION;

EID: 0035394094     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200107010-00016     Document Type: Letter

References (15)

1. The frequency of resistant mutant virus before antiviral therapy
2. Variations in HIV-1 pol gene associated with reduced sensitivity to antiretroviral drugs in treatment-naive patients
3. Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an International AIDS Society-USA Panel
4. Incidence and impact of resistance against approved antiretroviral drugs
5. Prevalence of primary HIV drug resistance among seroconverters during an explosive outbreak of HIV infection among injecting drug users
6. Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naive HIV-1 infected US military personnel
7. Identification of reverse transcriptase mutations associated with HIV-1 drug resistance mainly against non-nucleoside reverse transcriptase inhibitors in treatment-naive patients
8. Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study
9. Resistance against reverse transcriptase inhibitors
10. 3: AIDS Clinical Trials Group Protocol 208
11. Efavirenz response in non-nucleoside reverse transcriptase inhibitor-experienced patients: Results from the Sustiva Expanded Access Program
12. Complex interactions involving multiple amino acid substitutions alter non-nucleoside reverse transcriptase inhibitor susceptibility
13. Detection of drug resistance associated mutations in HIV primary infection within the UK
14. Transmission and prevalence of HIV resistance among treatment-naive subjects